NAFLD PREVALENCE AND PREDICTORS IN PATIENTS WITH T2D IN PRIMARY CARE INTERIM RESULTS FROM THE EPSONIP STUDY

被引：0

作者：

Balkhed, Wile ^{[1
]}

Nasr, Patrik ^{[2
]}

Forsgren, Mikael Fredrik ^{[3
]}

Bergram, Martin ^{[4
]}

Leinhard, Olof Dahlqvist

Dahlstrom, Nils ^{[4
]}

Carlhall, Carl-Johan ^{[4
]}

Lundberg, Peter ^{[4
]}

Radholm, Karin ^{[4
]}

Iredahl, Fredrik ^{[4
]}

Kechagias, Stergios ^{[2
]}

Ekstedt, Mattias ^{[2
]}

机构：

[1] Linkoping Univ, Dept Hlth Med & Caring Sci, Solna, Sweden

[2] Linkoping Univ, Dept Hlth Med & Caring Sci, Linkoping, Sweden

[3] Amra Med, Linkoping, Sweden

[4] Linkoping Univ, Linkoping, Sweden

来源：

HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

2077A

引用

页码：S844 / S845

页数：2

共 50 条

[1] NAFLD, BODY AND MUSCLE COMPOSITION PROFILE IN PATIENTS WITH T2D IN PRIMARY CARE - INTERIM RESULTS FROM THE EPSONIP STUDY
Balkhed, Wile
Forsgren, Mikael Fredrik
Nasr, Patrik
Bergram, Martin
Iredahl, Fredrik
Radholm, Karin
Carlhall, Carl-Johan
Dahlstrom, Nils
Lundberg, Peter
Kechagias, Stergios
Leinhard, Olof Dahlqvist
Ekstedt, Mattias
HEPATOLOGY, 2023, 78 : S1017 - S1018
[2] Evaluating the prevalence and severity of NAFLD in primary care: the EPSONIP study protocol
Patrik Nasr
Fredrik Iredahl
Nils Dahlström
Karin Rådholm
Pontus Henriksson
Gunnar Cedersund
Olof Dahlqvist Leinhard
Tino Ebbers
Joakim Alfredsson
Carl-Johan Carlhäll
Peter Lundberg
Stergios Kechagias
Mattias Ekstedt
BMC Gastroenterology, 21
[3] Evaluating the prevalence and severity of NAFLD in primary care: the EPSONIP study protocol
Nasr, Patrik
Iredahl, Fredrik
Dahlstrom, Nils
Radholm, Karin
Henriksson, Pontus
Cedersund, Gunnar
Leinhard, Olof Dahlqvist
Ebbers, Tino
Alfredsson, Joakim
Carlhall, Carl-Johan
Lundberg, Peter
Kechagias, Stergios
Ekstedt, Mattias
BMC GASTROENTEROLOGY, 2021, 21 (01)
[4] Prevalence of CVD and Evaluation of Standard of Care in T2D: A Nationwide Study in Primary Care
Rungby, Jorgen
Schou, Morten
Warrer, Per
Ytte, Lars
Andersen, Gert S.
DIABETES, 2017, 66 : A650 - A650
[5] A prospective cohort study for the prevalence and screening policy of NAFLD in patients with T2DM in primary care
Forlano, Roberta
Mullish, Benjamin H.
Yee, Michael
Goldin, Robert D.
Thursz, Mark
Manousou, Pinelopi
JOURNAL OF HEPATOLOGY, 2021, 75 : S558 - S559
[6] PREVALENCE OF ADVANCED LIVER FIBROSIS AMONG PRIMARY CARE PATIENTS WITH NAFLD. RESULTS FROM GENERAL PRACTITIONER DATABASE NAFLD (GPS-NAFLD) STUDY.
Miele, Luca
Lapi, Francesco
Grattagliano, Ignazio
Liguori, Antonio
Dajko, Marianxhela
Marrone, Giuseppe
Biolato, Marco
Napodano, Cecilia
De Magistris, Antonio
Rapaccini, Gianludovico
Rossi, Alessandro
Gasbarrini, Antonio
Cricelli, Claudio
Grieco, Antonio
HEPATOLOGY, 2020, 72 : 988 - 988
[7] Prevalence of Timely (TI), Delayed (DI) and No Intensifi cation (NI) of T2D Treatment and Predictors of TI in T2D Patients Uncontrolled on Basal Insulin (BI)
Levin, Philip
Zhou, Steve
Fan, Tao
Song, Xue
Nero, Damion
Davis, Brian
Chu, Bong-Chul
DIABETES, 2016, 65 : A240 - A240
[8] T2D Genetic Risk Counseling & Testing in Primary Care
Cho, Alex
Vorderstrasse, Allison
Suchindran, Sunil
Lucas, Joseph
Scott, William Michael
Bembe, Marylou
Baker, Dana
Haga, Susanne B.
Orlando, Lori
Trujillo, Gloria M.
Joy, Scott V.
Ginsburg, Geoffrey S.
DIABETES, 2013, 62 : A196 - A196
[9] Fibrosis 4 Index Related to Microalbuminuria in Tibetan Patients with T2D and NAFLD
Zhang, Chenghui
DIABETES, 2022, 71
[10] Finerenone and Kidney Outcomes in Patients with CKD and T2D: Results from FIDELITY
Bakris, George L.
Ruilope, Luis M.
Anker, Stefan D.
Filippatos, Gerasimos
Pitt, Bertram
Rossing, Peter
Fried, Linda F.
Roy-Chaudhury, Prabir
Sarafidis, Pantelis
Ahlers, Christiane
Joseph, Amer
Brinker, Meike D.
Lawatscheck, Robert
Agarwal, Rajiv
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : B6 - B6

← 1 2 3 4 5 →